Evidence map›Paper›PMID 42291322›Full record

ArticleFrontiers in cellular and infection microbiology2026

Temporal upregulation of TREM2 parallel to M2 macrophage marker expression in tuberculosis: implications for macrophage polarization regulation.

Xiaoqian Shang, Naifeisha Maimaiti, Fengming Tian, Chunbo Liao, Hu Sun, Xuan Zhou, Weina Kong, Qiannan Sun, Liang Wang, Xiumin Ma

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoqian Shang *Clinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.
Naifeisha Maimaiti *Department of Pathology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumuqi, Xinjiang, China.
Fengming TianClinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.
Chunbo LiaoClinical Laboratory Center, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Hu SunThe Frist Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xuan ZhouClinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.
Weina KongClinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.
Qiannan SunClinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.
Liang WangThe Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xiumin MaClinical Laboratory Center, The third Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Key Laboratory of High Incidence Diseases in Research in Xinjiang (Xinjiang Medical University), Ministry of Education, Urumqi, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aims to explore the association between Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) expression and tuberculosis pathogenesis, with particular focus on its potential correlation with established macrophage polarization markers. Methods: The inflammatory pathology of lung tissues in mock-infected mice was evaluated using hematoxylin and eosin (H&E) staining. Additionally, the expression and localization of M1/M2 macrophage-specific markers and TREM2 were assessed via immunohistochemical (IHC) staining. The expression levels and localization of M1/M2 macrophage-associated cytokines, including IL-10 and IL-6, were measured in peripheral blood using enzyme-linked immunosorbent assay (ELISA) and quantitative real-time PCR (qRT-PCR). Results: I In the experimental group of mice, lung lesions exhibited widened alveolar septa, interstitial edema, and extensive infiltration of inflammatory cells and erythrocytes. TREM2 and inflammatory markers (iNOS and IL-10) showed significant positive expression in the infected lung tissues. Compared to the control group, the Mycobacterium-infected mouse model displayed significantly higher mRNA expression levels of TREM2, along with increased IL-10 and IL-6 production. Following co-culture with Conclusion: TREM2 expression was significantly upregulated in lung tissues of tuberculosis-infected murine models, correlating strongly with increased expression of macrophage-derived cytokines. Notably,

Indexed as

MacrophagesMembrane GlycoproteinsReceptors, ImmunologicTuberculosisAnimalsBiomarkersCoculture TechniquesCytokinesDisease Models, AnimalFemaleHumansInterleukin-10LungMacrophage ActivationMaleMiceBiomarkersCytokinesInterleukin-10Membrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanTrem2 protein, mousemacrophageMycobacterium smegmatispolarizationTREM2tuberculosis

Identifiers

PMID42291322
PMCPMC13259949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.